Market Insights Digital Digital Health Digital Treatment & Care

Digital Therapeutics - France

France

Revenue in the Digital Therapeutics market is projected to reach €18.48m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2028) of 17.99%, resulting in a projected market volume of €35.82m by 2028.
User penetration will be 0.82% in 2024 and is expected to hit 1.39% by 2028.
The average revenue per user (ARPU) is expected to amount to €34.10.
In global comparison, most revenue will be generated in the United States (€2,877.00m in 2024).

Marché

Région

Comparaison de régions

Monnaie

Analyst Opinion

The Digital Therapeutics market in France is experiencing significant growth and development, particularly in the areas of Diabetes care, Mental & Behavioral health, Cardiovascular Health, and Musculoskeletal Health.

Customer preferences: Customers in France are increasingly turning to Digital Therapeutics products to manage their health conditions due to the convenience and accessibility they offer. The ease of monitoring and tracking health metrics remotely through digital platforms is appealing to individuals looking for more personalized and proactive healthcare solutions.

Trends in the market: In France, there is a growing trend towards the integration of Digital Therapeutics into traditional healthcare systems. Healthcare providers are recognizing the potential of these digital solutions to improve patient outcomes and reduce healthcare costs. Additionally, there is an increasing focus on evidence-based Digital Therapeutics products that have been clinically validated to ensure their effectiveness.

Local special circumstances: France has a well-established healthcare system with a strong emphasis on preventive care and patient education. This focus aligns well with the goals of Digital Therapeutics, which aim to empower individuals to take control of their health through education, monitoring, and behavior change interventions. The regulatory environment in France also supports the adoption of Digital Therapeutics, providing a clear framework for market entry and reimbursement.

Underlying macroeconomic factors: The increasing prevalence of chronic diseases in France, such as diabetes, cardiovascular conditions, and musculoskeletal disorders, is driving the demand for innovative healthcare solutions like Digital Therapeutics. Additionally, the aging population and rising healthcare costs are putting pressure on the healthcare system to find more efficient and cost-effective ways to deliver care, making Digital Therapeutics an attractive option for both patients and providers. The growing digital infrastructure and tech-savvy population in France further support the expansion of the Digital Therapeutics market in the country.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on revenues and user data of relevant mobile applications and consumer electronics companies.

Modeling approach / Market size:

Market sizes are determined through a combined top-down and bottom-up approach, building on a specific rationale for each market segment. As a basis for evaluating markets, we use annual financial reports of key players, industry reports, third-party reports, and survey results from primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as GDP, population, internet penetration, smartphone penetration, consumer spending, and healthcare spending. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, the S-curve function and exponential trend smoothing are well suited for forecasting digital products and services due to the non-linear growth of technology adoption.

Additional notes:

The market is updated twice a year in case market dynamics change. The impact of the COVID-19 pandemic and the Russia-Ukraine war is considered at a country-specific level.